MiniSeq Cancer Research Applications
Please rotate your device for optimal viewing.
Illumina offers a rich interactive experience to introduce the MiniSeq system. To enjoy, please update your browser to Internet Explorer 10 and above or switch your browser to a current version of Chrome, Firefox or Safari.
Proceed to the MiniSeq System product page »
Proceed to the MiniSeq System product page »
Explore workflows
The simple and affordable MiniSeq System delivers robust performance with demonstrated workflows for both predefined and custom panels across cancer research applications. Here’s a quick snapshot.
Take a virtual tour
Experience the ease and simplicity of the MiniSeq System for yourself. From push-button operation to easy onboard data analysis, you’ll see how intuitive this library-to-results solution is.
To experience the full interactive system explorer, please view this page on your desktop using Chrome, Firefox, or Safari.
To view a video of the tour click the link below.
Explore key cancer research applications
- Advance your cancer research with proven Illumina NGS technology.
- Take a virtual tour of the MiniSeq System.
- Learn about its demonstrated workflows for cancer molecular profiling studies.
Those conducting translational or clinical cancer research should have access to the most efficient way of profiling hematological and solid tumors. Next-generation sequencing (NGS) can help you avoid costly iterative testing while simultaneously reducing the risk of depleting your samples. view infographic
SEQUENCE JUST ONCE Say you’re investigating colorectal cancer, targeting mutations in KRAS, NRAS, and BRAF genes — Illumina NGS makes analysis simple and efficient: |
|
KRAS qPCR Exon 2 (codons 12 and 13) and Exon 3 (codon 61) PYROSEQUENCING Exon 3 (codon 59) and Exon 4 (codons 117 and 146) NRAS PYROSEQUENCING Exon 2 (codons 12 and 13), Exon 3 (codons 59 and 61), and Exon 4 (codons 117 and 146) BRAF qPCR V600E, D, K, and R |
With qPCR and pyrosequencing, you would need  |
KRAS, NRAS, AND BRAF NGS covers all of the above codons |
With Illumina NGS, you could assess everything with 2 REACTION |
SAVE ON SAMPLE MATERIAL This leaves more sample material available for further investigation, if necessary |
|
MINIMIZE WORKFLOW PROTOCOLS |
|
qPCR and pyrosequencing would require maintaining 3 workflow protocols: |
Illumina NGS would require maintaining only a single workflow protocol |
  |
 |
SIMPLIFY REPORTING |
|
Between qPCR and pyrosequencing, you would need to consolidate 3 different reports, one for each assessment    |
With Illumina NGS, you would get one report inclusive of all relevant genes  |
The MiniSeq System
Explore the possibilities
Discover demonstrated workflows for cancer research.
view workflows
view system explorerTo experience the full interactive system explorer,
please switch your browser to Chrome, Firefox, or Safari.
Get your questions answered
We’re here to answer any questions you might have about the system itself or next-generation sequencing (NGS) in general. Just fill out the contact form. We look forward to helping you realize the proven power of Illumina NGS.
Keep exploring
We hope you enjoyed taking a virtual tour of the MiniSeq System and learning about its demonstrated workflows and many advantages for oncology research. Simple, small, and affordable, this solution makes NGS accessible for any lab.
Return to MiniSeq Contact UsInnovative technologies
At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.
For Research Use Only. Not for use in diagnostic procedures (except as specifically noted).
© 2016 Illumina, Inc. All rights reserved.